Cargando…
Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge
Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile anesthetics and succinylcholine. Rarely, MH can occur after non-pharmacological triggers too. MH was detected more often in children and young adults, which makes this topic very important for every ped...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717737/ https://www.ncbi.nlm.nih.gov/pubmed/36360420 http://dx.doi.org/10.3390/children9111692 |
_version_ | 1784842950712229888 |
---|---|
author | Klincová, Martina Štěpánková, Dagmar Schröderová, Ivana Klabusayová, Eva Štourač, Petr |
author_facet | Klincová, Martina Štěpánková, Dagmar Schröderová, Ivana Klabusayová, Eva Štourač, Petr |
author_sort | Klincová, Martina |
collection | PubMed |
description | Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile anesthetics and succinylcholine. Rarely, MH can occur after non-pharmacological triggers too. MH was detected more often in children and young adults, which makes this topic very important for every pediatric specialist, both anesthesiologists and intensivists. MH crisis is a life-threatening severe hypermetabolic whole-body reaction. Triggers of MH are used in pediatric intensive care unit (PICU) as well, volatile anesthetics in difficult sedation, status asthmaticus or epilepticus, and succinylcholine still sometimes in airway management. Recrudescence or delayed onset of MH crisis hours after anesthesia was previously described. MH can also be a cause of rhabdomyolysis and hyperpyrexia in the PICU. In addition, patients with neuromuscular diseases are often admitted to PICU and they might be at risk for MH. The most typical symptoms of MH are hypercapnia, tachycardia, hyperthermia, and muscle rigidity. Thinking of the MH as the possible cause of deterioration of a patient’s clinical condition is the key to early diagnosis and treatment. The sooner the correct treatment is commenced, the better patient´s outcome. This narrative review article aims to summarize current knowledge and guidelines about recognition, treatment, and further management of MH in PICU. |
format | Online Article Text |
id | pubmed-9717737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97177372022-12-03 Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge Klincová, Martina Štěpánková, Dagmar Schröderová, Ivana Klabusayová, Eva Štourač, Petr Children (Basel) Review Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile anesthetics and succinylcholine. Rarely, MH can occur after non-pharmacological triggers too. MH was detected more often in children and young adults, which makes this topic very important for every pediatric specialist, both anesthesiologists and intensivists. MH crisis is a life-threatening severe hypermetabolic whole-body reaction. Triggers of MH are used in pediatric intensive care unit (PICU) as well, volatile anesthetics in difficult sedation, status asthmaticus or epilepticus, and succinylcholine still sometimes in airway management. Recrudescence or delayed onset of MH crisis hours after anesthesia was previously described. MH can also be a cause of rhabdomyolysis and hyperpyrexia in the PICU. In addition, patients with neuromuscular diseases are often admitted to PICU and they might be at risk for MH. The most typical symptoms of MH are hypercapnia, tachycardia, hyperthermia, and muscle rigidity. Thinking of the MH as the possible cause of deterioration of a patient’s clinical condition is the key to early diagnosis and treatment. The sooner the correct treatment is commenced, the better patient´s outcome. This narrative review article aims to summarize current knowledge and guidelines about recognition, treatment, and further management of MH in PICU. MDPI 2022-11-04 /pmc/articles/PMC9717737/ /pubmed/36360420 http://dx.doi.org/10.3390/children9111692 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Klincová, Martina Štěpánková, Dagmar Schröderová, Ivana Klabusayová, Eva Štourač, Petr Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge |
title | Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge |
title_full | Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge |
title_fullStr | Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge |
title_full_unstemmed | Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge |
title_short | Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge |
title_sort | malignant hyperthermia in picu—from diagnosis to treatment in the light of up-to-date knowledge |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717737/ https://www.ncbi.nlm.nih.gov/pubmed/36360420 http://dx.doi.org/10.3390/children9111692 |
work_keys_str_mv | AT klincovamartina malignanthyperthermiainpicufromdiagnosistotreatmentinthelightofuptodateknowledge AT stepankovadagmar malignanthyperthermiainpicufromdiagnosistotreatmentinthelightofuptodateknowledge AT schroderovaivana malignanthyperthermiainpicufromdiagnosistotreatmentinthelightofuptodateknowledge AT klabusayovaeva malignanthyperthermiainpicufromdiagnosistotreatmentinthelightofuptodateknowledge AT stouracpetr malignanthyperthermiainpicufromdiagnosistotreatmentinthelightofuptodateknowledge |